Studies on other DNA-PKi, and also inhibitors of ATM, ATR and PARP, did not find any therapeutically exploitable differences between photon and proton irradiation in HNSCC cell lines [94,95]. This evidence concerns the gene ATM and head and neck squamous cell carcinoma.